Skip Nav Destination
Inhibiting ERK5 Overcomes Breast Cancer Resistance to Anti-HER2 Therapy By Targeting the G1–S Cell-Cycle Transition
Cancer Research Communications (2022) 2 (3): 131–145.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Duncan C. Miller
- Suzannah J. Harnor
- Mathew P. Martin
- Richard A. Noble
- Stephen R. Wedge
- Celine Cano
Journal of Medicinal Chemistry (2023) 66 (7): 4491.
- Vincent Gureghian
- Hailee Herbst
- Ines Kozar
- Katarina Mihajlovic
- Noël Malod-Dognin
- Gaia Ceddia
- Cristian Angeli
- Christiane Margue
- Tijana Randic
- Demetra Philippidou
- Milène Tetsi Nomigni
- Ahmed Hemedan
- Leon-Charles Tranchevent
- Joseph Longworth
- Mark Bauer
- Apurva Badkas
- Anthoula Gaigneaux
- Arnaud Muller
- Marek Ostaszewski
- Fabrice Tolle
- Nataša Pržulj
- Stephanie Kreis
Cancer Gene Therapy (2023) 30 (10): 1330.
